Literature DB >> 2876745

Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension.

.   

Abstract

A series of 1418 men and 1,347 women with mild hypertension (diastolic phase V 90-109 mm Hg) aged 35-64 who had either had long term antihypertensive treatment with bendrofluazide or propranolol or taken placebo tablets for a similar period were randomly allocated to groups in which their tablets were either stopped or continued. The course of blood pressure and of biochemical variables was followed up for two years. Mean blood pressures rose rapidly after the withdrawal of active treatment, and between nine months and one year after stopping treatment the antihypertensive effect had almost disappeared. The effect persisting longer than this, and possibly due to resetting of the baroreceptors or of other blood pressure control mechanisms, was very small, and as the rise in mean pressure was due to an upward movement in general distribution there was no evidence of a subgroup in whom these mechanisms had been permanently reset to a clinically important extent. After withdrawal of propranolol the rise in pressure was more rapid in younger than in older people. After stopping bendrofluazide pressure rose more rapidly in men who had had higher pressures before and during treatment; this effect was not seen in women. Disturbances in biochemical variables associated with drug treatment had largely resolved by the end of two years after withdrawal. Stopping placebo tablets made no consistent difference to blood pressure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876745      PMCID: PMC1341775          DOI: 10.1136/bmj.293.6553.988

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  Arterial pressure responses to discontinuing antihypertensive drugs.

Authors:  H P Dustan; I H Page; R C Tarazi; E D Frohlich
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

2.  Seasonal variation in arterial blood pressure.

Authors:  P J Brennan; G Greenberg; W E Miall; S G Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

3.  Persistence of normal BP after withdrawal of drug treatment in mild hypertension.

Authors:  P D Levinson; I M Khatri; E D Freis
Journal:  Arch Intern Med       Date:  1982-12
  3 in total
  24 in total

Review 1.  Prehypertension: a possible target for antihypertensive medication.

Authors:  S D Nesbitt; S Julius
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 2.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

3.  Clinical predictors of treatment reduction in hypertensive patients.

Authors:  J F Steiner; S D Fihn; T D Koepsell; B Blair; K Kelleher; D D'Alessandro; T S Inui
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

Review 4.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 5.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

6.  The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.

Authors:  Tatiana V Macfarlane; Filippo Pigazzani; Robert W V Flynn; Thomas M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2018-11-28       Impact factor: 4.335

7.  Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort.

Authors:  Mark R Nelson; Chris M Reid; Henry Krum; Tui Muir; Philip Ryan; John J McNeil
Journal:  BMJ       Date:  2002-10-12

8.  TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.

Authors:  Martina Chittani; Roberta Zaninello; Chiara Lanzani; Francesca Frau; Maria F Ortu; Erika Salvi; Giovanni Fresu; Lorena Citterio; Daniele Braga; Daniela A Piras; Simona Delli Carpini; Dinesh Velayutham; Marco Simonini; Giuseppe Argiolas; Simona Pozzoli; Chiara Troffa; Valeria Glorioso; Kimmo K Kontula; Timo P Hiltunen; Kati M Donner; Stephen T Turner; Eric Boerwinkle; Arlene B Chapman; Sandosh Padmanabhan; Anna F Dominiczak; Olle Melander; Julie A Johnson; Rhonda M Cooper-Dehoff; Yan Gong; Natalia V Rivera; Gianluigi Condorelli; Bruno Trimarco; Paolo Manunta; Daniele Cusi; Nicola Glorioso; Cristina Barlassina
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

9.  Individual and work-unit measures of psychological demands and decision latitude and the use of antihypertensive medication.

Authors:  S Daugaard; J H Andersen; M B Grynderup; Z A Stokholm; R Rugulies; Å M Hansen; A Kærgaard; S Mikkelsen; J P Bonde; J F Thomsen; K L Christensen; H A Kolstad
Journal:  Int Arch Occup Environ Health       Date:  2014-07-06       Impact factor: 3.015

Review 10.  Future approaches to the treatment of hypertension in the light of results from recent trials.

Authors:  S G Ball
Journal:  Drugs       Date:  1988       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.